Zia Poonja

Dr. Zia Poonja

BC Cancer, Victoria, British Columbia, Canada
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
AGAnagha Gogate
Anagha Gogate
BBBryan Bennett
Bryan Bennett
ZPZia Poonja
Zia Poonja
GSGrant Stewart
Grant Stewart
ACAna Medina Colmenero
Ana Medina Colmenero
RMRobert Metcalf
Robert Metcalf
This study examined the real-world use of nivolumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). This was a multinational retrospective study (VOLUME) assessing treatment effectiveness and safety outcomes and a prospective study (VOLUME-PRO) assessing HRQoL and patient-reported symptoms. There were 447 and 51 patients in VOLUME and VOLUME-PRO, respectively. Across both studies, the median age was 64.0 years, 80.9% were male, and 52.6% were former smokers. Clinical outcomes of interest included real-world overall survival (rwOS) and real-world progression-free survival (rwPFS). The median rwOS was 9.2 months. Among patients with at least one assessment, 21.7% reported their best response as ‘partial response’, with 3.9% reporting ‘complete response’. The median duration of response (DoR) and median rwPFS were 11.0 months and 3.9 months, respectively. At baseline, VOLUME-PRO patients reported difficulties relating to fatigue, physical and sexual functioning, dyspnea, nausea, sticky saliva, dry mouth, pain/discomfort, mobility, and financial difficulties. There were improvements in social functioning and financial difficulties throughout the study; however, no other clinically meaningful changes were noted. No new safety concerns were identified. This real-world, multinational, multicenter, retrospective and prospective study supports the effectiveness and safety of nivolumab for R/M SCCHN patients.

1 March 2014 in Current Opinion in Supportive & Palliative Care
Verified
Journal Article
Closed access
CSChristine Simmons
Christine Simmons
YRYanchini Rajmohan
Yanchini Rajmohan
ZPZia Poonja
Zia Poonja
RARachel Adilman
Rachel Adilman
To examine the current data supporting use of social media in breast cancer clinical care. Although opportunities to utilize social media to increase knowledge have been commonly seized, the opportunity to improve communication among clinicians is lagging. Locally advanced breast cancer (LABC) requires timely coordination of care among many specialists, and presents an excellent scenario for enhanced utilization of current IT strategies. A systematic review was conducted to assess the use of social media to enhance breast cancer care. In addition, a Web-based search using common search engines and publicly available social media was conducted to determine the prevalence of information and networking pages aimed at patients and clinicians. Over 400 articles were retrieved; 81% focused on delivery of information or online support to patients, 17% focused on delivery of information to physicians, and 1% focused on the use of social media to improve collaboration among clinicians. Web searches retrieved millions of hits, with very few hits relating to improving collaboration among clinicians. Although there is significant potential to utilize current technologies to improve care for patients and improve connectedness among clinicians, most of the currently available technologies focus solely on the delivery of information.

20 August 2025 in Lung Cancer
Verified
Journal Article
Closed access
BMBarbara Melosky
Barbara Melosky
QCQuincy Chu
Quincy Chu
RJRosalyn Anne Juergens
Rosalyn Anne Juergens
Stephanie SnowStephanie Snow
Stephanie Snow
NBNormand Blais
Normand Blais
GLGeoffrey Liu
Geoffrey Liu

17 July 2015 in Canadian Urological Association Journal
Verified
Journal Article
Open access
PDF file
ZPZia Poonja
Zia Poonja
ASAlan So
Alan So
BEBernhard J. Eigl
Bernhard J. Eigl
Malignant obstructive uropathy can be a result of common genitourinary malignancies (i.e., ureter, prostate, bladder, or kidney) or extrinsic processes, such as colon and ovarian tumours. We present a case of uropathy caused by prostatic obstruction, which initially presented as a renal psuedo-tumour. We also review the relevant literature.